RCUS
RCUS
US03969F1093
Arcus Biosciences, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 247.000.000 258.000.000
4.3%
Cost of Revenue -- --
--
Gross Profit -- --
--
633.000.000 568.000.000
11.4%
Operating Income -386.000.000 -310.000.000
24.5%
Pretax Income -353.000.000 -282.000.000
25.2%
Net Income Common Stockholders -353.000.000 -283.000.000
24.7%
-- --
--
-- --
--
ende